Immunotherapy: A new era in the fight against cancer

Immunotherapy aims to expose cancer cells, allowing the immune system to recognize and destroy them. The most well-known forms of immunotherapy include CAR-T therapies, which modify the patient's T cells to attack cancer, and immune checkpoint inhibitors, which deactivate the switches in the immune system that allow cancer cells to evade detection.

Although these methods have made significant progress, they have limitations, with between 20% and 40% of patients responding to treatment. Researchers are exploring new approaches, such as high-fiber diets, statins, and combinations with other treatments, to improve the effectiveness of immunotherapy. Personalized vaccines represent a promising direction, showing encouraging results in recent studies.

Although there is still much to be done, immunotherapy proves to be a revolutionary tool in oncology, with the potential to radically transform cancer treatments.